Kivorent News

Wednesday, November 18, 2026

Health techNews

Noom unveils Noom Band, a screenless tracker for its employer obesity programs

Noom introduced Noom Band, a screenless wrist tracker built with Sensor Bio, and said every employer and health plan client will get it in 2027 at no added up-front cost.

Pulse, covering wearables and health sensors
, 3 min read

2027When Noom Health clients get the band

What to know

  • Noom Band tracks heart rate, heart rate variability (HRV), blood oxygen (SpO2), sleep and activity using sensors from Sensor Bio.
  • Noom says all Noom Health employer and health plan clients will get the band in 2027 with no additional up-front cost to the payer.
  • Noom's figures on weight loss and sleep with a wearable come from its own analyses, which it says have not been peer-reviewed.

Noom, the weight-loss app company, has introduced its own wearable. The company unveiled Noom Band at the HLTH USA 2026 conference in Las Vegas on November 16, 2026, and said it will build the device into the obesity and metabolic health programs it sells to employers and health plans.

Noom says every Noom Health employer and health plan client will get the band in 2027 "with no additional up-front cost to the payer." The release's subheadline puts the launch in early 2027. Noom did not give a consumer price, a battery life or a sale date for people outside those programs.

What the band measures

Fitt Insider describes Noom Band as a screenless wrist-worn device. The sensors and the raw-data platform come from Sensor Bio, an Austin, Texas, company that Fitt Insider says was formerly known as Biostrap. According to Noom, the band captures heart rate, heart rate variability (HRV), blood oxygen (SpO2), sleep and activity, and feeds those trends into Noom's coaching and behavior-change program.

Noom pitches the band as a tool for weight management rather than for athletes. Neither the release nor Fitt Insider mentions any FDA clearance, and nothing in the announcement says the band diagnoses or treats anything. Readers new to these measures can see what resting heart rate trends tell you, how smartwatches measure blood oxygen and what a sleep score measures.

Noom's own numbers

The release leans on two internal analyses, both of which Noom says have not been peer-reviewed.

  • In a look at 144,593 Noom Med users who signed up between September 2025 and July 2026, members on GLP-1 drugs who connected a wearable in their first month were 34% more likely to have lost 20 pounds by month four. That compares people who chose to connect a device with people who did not, so it shows an association, not that the wearable caused the weight loss.
  • Among 499 clinical-trial members who received the band, Noom reports an average of about 13 extra minutes of sleep a night over the first two months. For 103 members who started out sleeping under seven hours, the average was about 21 extra minutes a night.

The release's body text rounds these to 90 and 150 extra minutes a week. Its footnote also describes the second group as adding "1.5 nights of sleep per month," which does not match. This story uses the per-night figures from the footnote.

Where it fits

The band puts Noom alongside other health companies pairing their own sensors with paid care. Oura agreed to buy primary-care startup Counsel Health (our story), and Whoop has been adding services on top of its strap (Whoop Humans). Fitt Insider also names Withings and Hims & Hers. Noom is going the other way: it already sells the care program and is now adding the hardware.

Because the band goes to employer and health plan programs, the buyer is the payer, not the person wearing it. Noom chief executive Geoff Cook argues the company has already shown a return on investment through randomized trials and white papers, and the band is meant to strengthen that case to clients.

Why it matters

A weight-loss program that hands every enrolled member a heart rate and sleep tracker, paid for by the employer or insurer, could put wearables on many wrists that would never have bought one. Whether it improves outcomes is still unproven: Noom's figures so far are its own, unreviewed and observational.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

Sources

WearablesGlucose and metabolic techSleep techDigital health and AI in care

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.